{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:53:29Z","timestamp":1780332809668,"version":"3.54.1"},"reference-count":9,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[1984,6,1]],"date-time":"1984-06-01T00:00:00Z","timestamp":454896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr (Phila)"],"published-print":{"date-parts":[[1984,6]]},"abstract":"<jats:p>An infant exposed in utero to valproic acid was born with multiple congenital malformations, including duodenal atresia, lumbar vertebral fusion, thoracolumbar scoliosis, renal abnormalities, diastasis recti abdominis, depigmentation of the eye brows, and a large hemangioma. The child had neonatal hyperbilirubinemia and postnatal growth deficiency. This case report is an addition to the literature im plicating valproic acid as a human teratogen.<\/jats:p>","DOI":"10.1177\/000992288402300611","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T17:50:16Z","timestamp":1196099416000},"page":"352-353","source":"Crossref","is-referenced-by-count":21,"title":["Valproic Acid and Congenital Malformations"],"prefix":"10.1177","volume":"23","author":[{"given":"Maj Eric W.","family":"Bantz","sequence":"first","affiliation":[{"name":"USA, Department of Pediatrics, 97th General Hospital, Frankfurt, West Germany, APO New York 09757"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[1984,6,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198003203021204"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(75)80604-4"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80517-8"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6360.190"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90018-6"},{"key":"atypb6","first-page":"565","volume":"29","author":"Centers for Disease Control.","year":"1982","journal-title":"MMWR October"},{"key":"atypb7","unstructured":"Whittle BA Pre-clinical teratological studies on sodium valproate (Epilim) and other anticonvulsants. In: Legg NJ, ed. Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy. Turnbridge Wells, England: MSC Consultants, 1976:105-11."},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197713020-00001"},{"key":"atypb9","first-page":"768","volume":"219","author":"Nau H.","year":"1981","journal-title":"J Pharm Exp Ther"}],"container-title":["Clinical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/000992288402300611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/000992288402300611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:25:50Z","timestamp":1777393550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/000992288402300611"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[1984,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1984,6]]}},"alternative-id":["10.1177\/000992288402300611"],"URL":"https:\/\/doi.org\/10.1177\/000992288402300611","relation":{},"ISSN":["0009-9228","1938-2707"],"issn-type":[{"value":"0009-9228","type":"print"},{"value":"1938-2707","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,6]]}}}